home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

6.880 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Apr 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

7 Penny Stocks to Sell in June Before They Crash & Burn ↗

June 19, 2024

It's way past time to dump these seven struggling penny stocks before things go from bad to worse for investors.

Via InvestorPlace

Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗

June 11, 2024

These pharma and biotech players could become long-term winners.

Via The Motley Fool

3 Sorry Biotech Stocks to Sell in May While You Still Can ↗

May 31, 2024

Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell.

Via InvestorPlace

Ginkgo Bioworks Stock: Bull vs. Bear ↗

May 31, 2024

This innovative biotechnology company hopes to turn things around.

Via The Motley Fool

Should You Buy the Dip on Ginkgo Bioworks Stock? ↗

May 30, 2024

Its vision is ambitious, but can it actually be made to work?

Via The Motley Fool

3 Things You Need to Know if You Buy Ginkgo Bioworks Today ↗

May 25, 2024

It needs to work within the constraints imposed by these three issues.

Via The Motley Fool

How Is The Market Feeling About Ginkgo Bioworks Holdings? ↗

May 23, 2024

Via Benzinga

Is Ginkgo Bioworks Holdings Stock a Buy? ↗

May 18, 2024

Can this struggling stock turn things around?

Via The Motley Fool

Ginkgo Bioworks: Buy, Sell, or Hold? ↗

April 30, 2024

This company has a long way to go before investors will see rewards.

Via The Motley Fool

2 Cathie Wood Biotech Stocks That Could Be Worth the Risk ↗

May 29, 2024

You don't need to buy her picks, but it's worth understanding them.

Via The Motley Fool

Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF ↗

May 28, 2024

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.

Via Benzinga

Topics ETFs

Down 72%. Is Ginkgo Bioworks a Buy on the Dip? ↗

May 25, 2024

The number of cell engineering partnerships Ginkgo Bioworks has is way up, but the same can't be said about its stock price.

Via The Motley Fool

Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst ↗

May 20, 2024

Ginkgo Bioworks has become a penny stock -- and that's the least of its problems,

Via The Motley Fool

Investment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!' ↗

May 20, 2024

Ram Ahluwalia of Lumida Wealth pointed to Ark's flagship ETF trading over 70% below its all-time high amid the S&P 500's recent record highs.

Via Benzinga

Topics ETFs Stocks

Looking Into Ginkgo Bioworks Holdings's Recent Short Interest ↗

April 26, 2024

Via Benzinga

4 Small-Cap Value Stocks That Could Go Parabolic ↗

May 16, 2024

These four small-cap stocks scan as deeply undervalued right now.

Via The Motley Fool

What's the Difference Between Biotech Stocks and TechBio Stocks? ↗

May 15, 2024

A few enterprising businesses are marketing themselves differently.

Via The Motley Fool

TeraWulf Posts Weak Results, Joins StoneCo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

May 14, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 10, 2024

The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!

Via InvestorPlace

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 10, 2024

Via Benzinga

Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 10, 2024

Via Benzinga

DNA Stock Earnings: Ginkgo Bioworks Holdings Meets EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

DNA stock results show that Ginkgo Bioworks Holdings met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change' ↗

May 09, 2024

Ginkgo Bioworks reported quarterly sales of $38 million which missed the analyst consensus estimate of $46.044 million by 17.47% and is a 52.91% decrease in sales year-over-year. The company said the...

Via Benzinga

3 Meme Stocks to Sell in May Before They Crash & Burn ↗

May 08, 2024

Traders have gravitated to meme stocks over the past year. But it's time to sell these three before the party ends.

Via InvestorPlace

Want $10,000? Invest $1,000 in These 3 Penny Stocks Now ↗

May 07, 2024

Let's dive into these three high-potential penny stocks to discover whether or not they offer genuine investment opportunities.

Via InvestorPlace

Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today? ↗

April 30, 2024

Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering.

Via InvestorPlace

Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock? ↗

April 29, 2024

DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze.

Via InvestorPlace

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 29, 2024

Via Benzinga

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks. ↗

April 15, 2024

The collaboration could help solve challenges for both businesses.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com